Catheter Robot Atlas

Commercial and clinical-stage systems · rone_robocath2019

R-One

R-One / R-One+ (next-generation robot)
Robocath (acquired by Stereotaxis, closed 2026-07-07); Cathbot JV with MicroPort MedBot · 2019–2026
R-One: main picture1 / 6
Not cleared for distribution. https://www.robocath.com/wp-content/uploads/2023/04/visuel2.png (listed by robocath.com WordPress media API; page https://www.robocath.com/product/). Licence: press image (Robocath. Picture grade A.
Family
Commercial and clinical-stage systems (commercial)
Devices
0.014-in guidewire + rapid-exchange balloon/stent catheter; guide catheter manual. Next-gen: up to 5 devices simultaneously (press)
Degrees of freedom
3 (gao2026_legobot via S8); 2 in li2024_design (conflict)
Push
Other drives
Twist
Rolling between rollers
Tested up to
Human
Sim-to-real
None found — No simulation-trained controller found for this robot.

Testing

Highest level
Human
What was tested
R-EVOLUTION 62 pts, 6 sites; registrational trial 145 pts (MicroPort, press); FIH of 2nd-gen 2026 (press)
Key numbers
R-EVOLUTION: technical success 59/62 (95.2%), clinical success 100%, 3 conversions (1 robot-related); robotic 19.9+-9.6 of 39.9+-14.6 min; operator dose -84.5% under apron (durand2023_evaluation Results, partial). 15 systems installed worldwide (medtechdive, web).

Mechanism

Push (translation)
other: motorised pads combining translation and rotation
Twist (rotation)
same pads (coupled with translation)
Device range
N.R.
Target anatomy
coronary (PCI); carotid stenting reported

Sensing and interface

Force sensing
none
Leader and haptics
no
Imaging
standard fluoroscopy; robot placed on table beside patient (official photo)
Sterility
single-use cassette (clear cover visible in company photo)

Size

Footprint (mm)
N.R.
Mass (kg)
N.R.

Simulation

Simulation model
none found
Sim-trained controller
none found

Versions

Lineage
R-One (CE 2019); R-One+; second-generation robot (up to 5 devices, first-in-human started 2026-01-27, 20 pts planned); R-ONE (NMPA 2023-12-08 via Cathbot JV)

Sources

  1. Evaluation of the R-One robotic system for percutaneous coronary intervention: the R-EVOLUTION study · EuroIntervention, 2023 · doi:10.4244/eij-d-22-00642 [durand2023_evaluation]
  2. Robot-Assisted Cardiovascular Interventions · Journal of the Society for Cardiovascular Angiography & Interventions, 2025 · doi:10.1016/j.jscai.2025.102568 [george2025_robot]
  3. Robotic Systems in Cardiovascular Interventions: Evolving Platforms and the Path Forward · Methodist DeBakey Cardiovascular Journal, 2025 · doi:10.14797/mdcvj.1652 [mandhumula2025_robotic]

Notes

Notes
Stereotaxis agreed in April 2026 to buy Robocath for up to US$45M (US$20M upfront + US$25M milestones incl. FDA clearance of next-gen system); closing 2026-07-07 (Stereotaxis 10-Q via web summary; medtechdive fetched). No FDA clearance for R-One. NMPA approval for R-ONE 2023-12-08 (MicroPort HKEX filing, via search summary).

This record

Read level
partial — abstract/partial + web
Picture
https://www.robocath.com/wp-content/uploads/2023/04/visuel2.png (listed by robocath.com WordPress media API; page https://www.robocath.com/product/) ↗ — licence: press image (Robocath; grade A
Picture changes
cropped (30,30)-(1620,1000) of 1920x1014
Found by
commercial: Search of commercial and clinical-stage systems.
Data
JSON · YAML: records/robots/rone_robocath2019.yaml
Correction
Suggest a correction [repository not created yet]